Prospect Radar · 2026-08-31

Research candidates, NOT trade signals. Configuration: quiet name + first substantive touch by a graded author + no mechanics poison. Base rate: such touches precede a ±10% move ~1.5× more often than chance — direction unknown. These are names worth YOUR research today.

3006 — via @aleabitoreddit↗ (grade A)

• crowd: 1 authors / 2 signals · 5d run +0.0% · no listed options
• thesis: Discloses a position and presents a strongly bullish ESMT legacy-memory thesis
• receipt: tweet ↗

FN — via @crux_capital_ (grade A)

• crowd: 1 authors / 1 signals · 5d run -5.1% · no listed options
• thesis: Long-term thesis says capacity expansion and data-center growth support FN's strong future.
• receipt: tweet ↗

ASML — via @qualityequities↗ (grade A, hot hand)

• crowd: 3 authors / 3 signals · 5d run -3.8% · no listed options
• thesis: Author discloses a long ASML stance and argues its unique EUV position makes it highly valuable.
• receipt: tweet ↗

SOI — via @aleabitoreddit↗ (grade A)

• crowd: 5 authors / 5 signals · 5d run +0.0% · no listed options
• thesis: Bullish silicon-photonics thesis cites reservations, revenue floor and dominant substrate share
• receipt: tweet ↗

MYX.AX — via @puppyeh1↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Discloses continued accumulation based on undervaluation and a governance-change thesis.
• receipt: tweet ↗

WY — via @leevalueroach↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Calls WY dirt cheap and says it is something the author would hold as a cash alternative.
• receipt: tweet ↗

PRME — via @harry03994688↗ (grade A)

• crowd: 1 authors / 2 signals · 5d run +0.0% · no listed options
• thesis: Framework favors differentiated platforms and presents ABCL and PRME as high-potential small-cap examples.
• receipt: tweet ↗

POOL — via @AparicioCadiz↗ (grade A)

• crowd: 1 authors / 2 signals · 5d run +0.0% · no listed options
• thesis: Presents POOL as a contrarian cyclical opportunity amid weak construction but a growing installed base.
• receipt: tweet ↗

CYTK — via @bioinvestor24↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run -6.2% · no listed options
• thesis: Argues pharma LOE pressure makes valuable biotech assets likely acquisition targets.
• receipt: tweet ↗

EWTX — via @bioinvestor24↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Argues pharma LOE pressure makes valuable biotech assets likely acquisition targets.
• receipt: tweet ↗

SRRK — via @bioinvestor24↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Compares biotech takeover candidates and argues ABVX's price and safety risks limit appeal.
• receipt: tweet ↗